Which has stronger earnings and valuation, AVTR or RVTY?

Revvity has lower revenue, but higher earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avantor $6.55B 1.56 -$530.20M -$0.84 N/A Revvity $2.86B 6.00 $241.20M $2.10 73.17

Is AVTR or RVTY more profitable?

Revvity has a net margin of 8.16% compared to Avantor's net margin of -8.81%. Avantor's return on equity of 9.92% beat Revvity's return on equity. Company Net Margins Return on Equity Return on Assets Avantor -8.81% 9.92% 4.75% Revvity 8.16% 8.34% 5.01%

Which has higher valuation & earnings, AVTR or WAT?

Waters has lower revenue, but higher earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avantor $6.55B 1.56 -$530.20M -$0.84 N/A Waters $3.17B 13.66 $642.63M $4.01 109.74

Is AVTR or WAT more profitable?

Waters has a net margin of 3.58% compared to Avantor's net margin of -8.81%. Waters' return on equity of 11.27% beat Avantor's return on equity. Company Net Margins Return on Equity Return on Assets Avantor -8.81% 9.92% 4.75% Waters 3.58% 11.27% 6.73%

Which has better earnings and valuation, ILMN or AVTR?

Illumina has higher earnings, but lower revenue than Avantor. Avantor is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Illumina $4.34B 9.52 $850M $5.36 51.06 Avantor $6.55B 1.56 -$530.20M -$0.84 N/A

Is ILMN or AVTR more profitable?

Illumina has a net margin of 18.36% compared to Avantor's net margin of -8.81%. Illumina's return on equity of 29.84% beat Avantor's return on equity. Company Net Margins Return on Equity Return on Assets Illumina 18.36% 29.84% 12.17% Avantor -8.81% 9.92% 4.75%

Avantor (AVTR) Competitors

$15.09 -0.15 (-0.99%)

Closing price 09/30/2026 03:59 PM Eastern

Extended Trading

$15.06 -0.03 (-0.23%)

As of 09/30/2026 07:30 PM Eastern

Compare

AVTR vs. RVTY, TMO, WAT, ILMN, and MTD

Should you buy Avantor stock or one of its competitors? Avantor's main competitors and comparable companies include Revvity (RVTY), Thermo Fisher Scientific (TMO), Waters (WAT), Illumina (ILMN), and Mettler-Toledo International (MTD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Avantor compare to Revvity?

Avantor (NYSE:AVTR) and Revvity (NYSE:RVTY) are both large-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

95.1% of Avantor shares are held by institutional investors. Comparatively, 86.7% of Revvity shares are held by institutional investors. 0.3% of Avantor shares are held by insiders. Comparatively, 0.9% of Revvity shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Avantor currently has a consensus price target of $12.47, suggesting a potential downside of 17.35%. Revvity has a consensus price target of $116.57, suggesting a potential downside of 24.13%. Given Avantor's higher probable upside, equities research analysts plainly believe Avantor is more favorable than Revvity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avantor	1 Sell rating(s)	15 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.06
Revvity	0 Sell rating(s)	14 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

Revvity has lower revenue, but higher earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avantor	$6.55B	1.56	-$530.20M	-$0.84	N/A
Revvity	$2.86B	6.00	$241.20M	$2.10	73.17

Avantor has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, Revvity has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market.

Revvity has a net margin of 8.16% compared to Avantor's net margin of -8.81%. Avantor's return on equity of 9.92% beat Revvity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avantor	-8.81%	9.92%	4.75%
Revvity	8.16%	8.34%	5.01%

In the previous week, Revvity had 12 more articles in the media than Avantor. MarketBeat recorded 12 mentions for Revvity and 0 mentions for Avantor. Revvity's average media sentiment score of 0.34 beat Avantor's score of -0.27 indicating that Revvity is being referred to more favorably in the news media.

Company	Overall Sentiment
Avantor	Neutral
Revvity	Neutral

Summary

Revvity beats Avantor on 12 of the 16 factors compared between the two stocks.

How does Avantor compare to Thermo Fisher Scientific?

Avantor (NYSE:AVTR) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

In the previous week, Thermo Fisher Scientific had 20 more articles in the media than Avantor. MarketBeat recorded 20 mentions for Thermo Fisher Scientific and 0 mentions for Avantor. Thermo Fisher Scientific's average media sentiment score of 1.05 beat Avantor's score of -0.27 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Overall Sentiment
Avantor	Neutral
Thermo Fisher Scientific	Positive

Thermo Fisher Scientific has a net margin of 15.04% compared to Avantor's net margin of -8.81%. Thermo Fisher Scientific's return on equity of 17.09% beat Avantor's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avantor	-8.81%	9.92%	4.75%
Thermo Fisher Scientific	15.04%	17.09%	8.12%

95.1% of Avantor shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 0.3% of Avantor shares are owned by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Avantor has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market.

Avantor currently has a consensus price target of $12.47, suggesting a potential downside of 17.35%. Thermo Fisher Scientific has a consensus price target of $628.78, suggesting a potential downside of 7.23%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Avantor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avantor	1 Sell rating(s)	15 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.06
Thermo Fisher Scientific	2 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.77

Thermo Fisher Scientific has higher revenue and earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avantor	$6.55B	1.56	-$530.20M	-$0.84	N/A
Thermo Fisher Scientific	$44.56B	5.62	$6.70B	$18.59	36.46

Summary

Thermo Fisher Scientific beats Avantor on 15 of the 17 factors compared between the two stocks.

How does Avantor compare to Waters?

Avantor (NYSE:AVTR) and Waters (NYSE:WAT) are both large-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation, risk and media sentiment.

In the previous week, Waters had 12 more articles in the media than Avantor. MarketBeat recorded 12 mentions for Waters and 0 mentions for Avantor. Waters' average media sentiment score of 0.33 beat Avantor's score of -0.27 indicating that Waters is being referred to more favorably in the news media.

Company	Overall Sentiment
Avantor	Neutral
Waters	Neutral

Waters has lower revenue, but higher earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avantor	$6.55B	1.56	-$530.20M	-$0.84	N/A
Waters	$3.17B	13.66	$642.63M	$4.01	109.74

Waters has a net margin of 3.58% compared to Avantor's net margin of -8.81%. Waters' return on equity of 11.27% beat Avantor's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avantor	-8.81%	9.92%	4.75%
Waters	3.58%	11.27%	6.73%

Avantor has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, Waters has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market.

95.1% of Avantor shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 0.3% of Avantor shares are held by insiders. Comparatively, 0.3% of Waters shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Avantor currently has a consensus price target of $12.47, suggesting a potential downside of 17.35%. Waters has a consensus price target of $434.60, suggesting a potential downside of 1.24%. Given Waters' stronger consensus rating and higher possible upside, analysts clearly believe Waters is more favorable than Avantor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avantor	1 Sell rating(s)	15 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.06
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85

Summary

Waters beats Avantor on 15 of the 17 factors compared between the two stocks.

How does Avantor compare to Illumina?

Illumina (NASDAQ:ILMN) and Avantor (NYSE:AVTR) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Illumina has a net margin of 18.36% compared to Avantor's net margin of -8.81%. Illumina's return on equity of 29.84% beat Avantor's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	18.36%	29.84%	12.17%
Avantor	-8.81%	9.92%	4.75%

Illumina has higher earnings, but lower revenue than Avantor. Avantor is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.34B	9.52	$850M	$5.36	51.06
Avantor	$6.55B	1.56	-$530.20M	-$0.84	N/A

Illumina presently has a consensus price target of $209.75, indicating a potential downside of 23.36%. Avantor has a consensus price target of $12.47, indicating a potential downside of 17.35%. Given Avantor's higher probable upside, analysts plainly believe Avantor is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.44
Avantor	1 Sell rating(s)	15 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.06

89.4% of Illumina shares are owned by institutional investors. Comparatively, 95.1% of Avantor shares are owned by institutional investors. 2.9% of Illumina shares are owned by company insiders. Comparatively, 0.3% of Avantor shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Illumina had 12 more articles in the media than Avantor. MarketBeat recorded 12 mentions for Illumina and 0 mentions for Avantor. Illumina's average media sentiment score of 0.57 beat Avantor's score of -0.27 indicating that Illumina is being referred to more favorably in the media.

Company	Overall Sentiment
Illumina	Positive
Avantor	Neutral

Illumina has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market. Comparatively, Avantor has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market.

Summary

Illumina beats Avantor on 13 of the 16 factors compared between the two stocks.

How does Avantor compare to Mettler-Toledo International?

Mettler-Toledo International (NYSE:MTD) and Avantor (NYSE:AVTR) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

Mettler-Toledo International has higher earnings, but lower revenue than Avantor. Avantor is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.03B	7.53	$869.19M	$44.43	34.05
Avantor	$6.55B	1.56	-$530.20M	-$0.84	N/A

Mettler-Toledo International currently has a consensus price target of $1,446.36, indicating a potential downside of 4.40%. Avantor has a consensus price target of $12.47, indicating a potential downside of 17.35%. Given Mettler-Toledo International's stronger consensus rating and higher possible upside, equities analysts clearly believe Mettler-Toledo International is more favorable than Avantor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	1 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.31
Avantor	1 Sell rating(s)	15 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.06

Mettler-Toledo International has a net margin of 21.91% compared to Avantor's net margin of -8.81%. Avantor's return on equity of 9.92% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.91%	-1,212.14%	25.11%
Avantor	-8.81%	9.92%	4.75%

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 95.1% of Avantor shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by company insiders. Comparatively, 0.3% of Avantor shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Mettler-Toledo International has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market. Comparatively, Avantor has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market.

In the previous week, Mettler-Toledo International had 7 more articles in the media than Avantor. MarketBeat recorded 7 mentions for Mettler-Toledo International and 0 mentions for Avantor. Mettler-Toledo International's average media sentiment score of 0.38 beat Avantor's score of -0.27 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company	Overall Sentiment
Mettler-Toledo International	Neutral
Avantor	Neutral

Summary

Mettler-Toledo International beats Avantor on 13 of the 16 factors compared between the two stocks.

Get Avantor News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVTR vs. The Competition

Export

Metric	Avantor	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$10.31B	$10.99B	$7.30B	$22.83B
Dividend Yield	N/A	1.45%	2.52%	3.72%
P/E Ratio	-17.96	75.41	273.69	27.52
Price / Sales	1.56	110.40	659.86	21.29
Price / Cash	10.06	27.54	79.75	40.95
Price / Book	1.85	6.80	10.34	4.60
Net Income	-$530.20M	$57.48B	$3.50B	$1.08B
7 Day Performance	-1.92%	2.54%	-1.34%	-1.44%
1 Month Performance	6.04%	8.98%	-4.64%	-4.90%
1 Year Performance	10.26%	35.66%	11.06%	4.77%

Avantor Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVTR Avantor	0.9703 of 5 stars	$15.09 -1.0%	$12.47 -17.4%	+20.9%	$10.31B	$6.55B	N/A	13,500
RVTY Revvity	3.0091 of 5 stars	$143.66 +0.1%	$116.57 -18.9%	+75.2%	$16.01B	$2.86B	68.41	11,000
TMO Thermo Fisher Scientific	4.3653 of 5 stars	$659.44 +1.2%	$624.64 -5.3%	+39.8%	$240.87B	$44.56B	35.47	125,000	Positive News
WAT Waters	2.2704 of 5 stars	$424.33 +0.6%	$434.60 +2.4%	+46.8%	$41.42B	$3.17B	105.82	7,900
ILMN Illumina	1.9293 of 5 stars	$238.82 -0.3%	$199.13 -16.6%	+188.2%	$36.18B	$4.34B	44.56	8,650	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AVTR) was last updated on 10/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avantor (AVTR) Competitors